BIOTHRAX

This brand name is authorized in Poland, Singapore, United Kingdom, United States

Active ingredients

The drug BIOTHRAX contains one active pharmaceutical ingredient (API):

1 Anthrax antigen UNII 873OI62848 - BACILLUS ANTHRACIS STRAIN V770-NP1-R ANTIGENS

Anthrax antigen induces antibodies raised against PA that may contribute to protection by neutralizing the activities of the cytotoxic lethal toxin and edema toxin of Bacillus anthracis. Read about Anthrax antigen

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
BIOTHRAX Suspension for injection	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J07AC01	Anthrax antigen	J Antiinfectives for systemic use → J07 Vaccines → J07A Bacterial vaccines → J07AC Anthrax vaccines
Discover more medicines within J07AC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 368315, 368316
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100397951
Country: SG	Health Sciences Authority	Identifier(s): 13967P
Country: US	FDA, National Drug Code	Identifier(s): 64678-211